Abstract To investigate the contribution and mechanism of eosinophil granulocytes and NK cells-mediated cytotoxicity to the pathogenesis of ITP. Mononuclear cells and platelets were prepared from the bone marrow of 16 ITP patients and 10 healthy controls. Separately, eosinophil granulocytes and NK cells were selected with magnetic microbeads. As the target cells, the autologous platelets were cultured with eosinophil granulocytes and NK cells respectively for 6 h and then stained with annexin V. Ratio of platelets expressing annexin V was determined by flow cytometry. The fraction of NK cells expressing perforin, granzyme B, FasL and TNF were determined by flow cytometry. Human eosinophil cationic protein (ECP) level in the bone marrow was determined by ECP ELISA kit. The annexin V positive platelet ratio of the ITP group was significantly higher than that of the control group; the expression rates of granzyme B, perforin, FasL on NK cells of the ITP group were significantly higher than those of the control group. Expression of human ECP in bone marrow of immune thrombocytopenia patients was higher than that of healthy controls. NK cells and eosinophil granulocytes are activated in ITP and might be involved in the pathogenesis of ITP.
Introduction
Immune thrombocytopenia (ITP) is an acquired disorder characterized by mild to severe thrombocytopenia. Historically ITP-associated thrombocytopenia was attributed solely to sequestration of autoantibody-sensitized platelet in the reticuloendothelial system. However, humoral mechanisms cannot account for all observations made in this disorder, and it is increasingly evident that cellular mechanisms contribute to platelet destruction [1, 2] .
We have developed a novel system by using eosinophil granulocytes and NK cells to study the cytotoxicity of specific cell towards patient's autologous platelets.
Materials and Methods

Patients
Bone marrow was collected from 16 patients (5 males and 11 females) with ITP and 10 healthy donors. The patients were aged between 14 and 66 (mean 33) years. They were all newly diagnosed and met the diagnostic criteria for ITP as evidenced isolated thrombocytopenia, normal or increased number of megakaryocytes in bone marrow biopsies, absence of splenomegaly and exclusion of other known causes of thrombocytopenia (such as connective tissue disease, malignancy, human immunodeficiency virus (HIV) or drug-induced disorders). The platelet counts of all patients were lower than 100 9 10 9 /L, ranging between 5 and 60 9 10 9 /L at the time of bone marrow sampling, and none of the patients received corticosteroids or other immunosuppressive agent therapy before bone marrow sampling. Control bone marrow was obtained from 10 healthy donors with no history of blood transfusion, 
Flow Cytometric Analysis
Assay for eosinophil granulocytes and NK cell-mediated cytotoxicity toward platelets was performed with a Beckman Coulter Cytomics FC 500 flow cytometer (Beckman Coulter, USA). The eosinophil granulocytes and NK cells were used as effector cells respectively and autologous platelets were used as target cells. Effector cells and target cells were incubated for 6 h in RPMI 1640 culture medium supplemented with plasma of ITP patient at a ratio of 100 platelets to one effector cell at 37°C in CO 2 incubator.
Thereafter aliquots of the cell suspension were incubated with FITC-conjugated Annexin V. Logarithmic amplifiers were used for fluorescence signals, and 10,000 events were collected. A platelets gate was set in the forward light scatter and side-scatter dotplot to distinguish platelets from effector cells. The fraction of platelets expressing Annexin V was analyzed using the CXP Analysis software (Beckman Coulter, USA).
Immunofluorescence flow cytometry was also used to measure the molecules involved in NK-mediated cytotoxicity. The cell concentration was adjusted to 10 9 /L. Aliquots of the cell suspension were added with 20 lL PE or FITC-conjugated mAbs, FasL-PE and TNF-a-FITC, respectively. Appropriate isotype matched control antibodies were used. After incubation for 30 min on ice in the dark, the surface expression in CD16
? CD56 ? cells was evaluated by flow cytometry. Logarithmic amphfiers were used for fluorescence signals and 10,000 events were collected. The fraction of NK cells expressing FasL and TNFa were determined by setting a quadrant gate in the fluorescence dotplot for NK cells.
The Determination of ECP Concentrations
The ECP level in the bone marrow was analyzed with the ECP ELISA kit strictly following the instructions of the kit.
Statistics
Data were reported as mean ± SD. Differences between groups were evaluated using the Student's t test for analysis of completely randomized two-group designs. P values \0.05 were considered statistically significant. Sample size was determined by PASS 11.0 for two-sample t test power analysis. Table 1 depicted the data obtained from the 16 ITP patients and 10 healthy donors and the results were from flow cytometry. When platelets were placed in culture with media supplemented with plasma of ITP alone, the differences of Annexin V positive platelets ratios between the ITP patients and the controls were not statistically significant (3.59 ± 1.08 vs 3.50 ± 0.96). Annexin V-FITC positive platelets in ITP group (11.10 ± 1.75, 14.69 ± 2.21) in which the NK cells or eosinophil granulocytes were used as effector cells were significantly higher than those of normal control (3.62 ± 0.88, 3.74 ± 0.78).
Results
Cell-mediated lysis of autologous platelets in ITP
Expression of the molecules involved in NK-mediated cytotoxicity
The cells of ITP patients (n = 16) and normal controls (n = 10) were labeled using PE or FITC conjugated antiFasL, anti-human granzyme B, anti-human perforin and anti-TNF-a mAbs, respectively. Flow cytometry was used to measure these molecules levels in NK cells. As shown in 
The determination of ECP concentrations in the bone marrow
According to the manufacturer's instructions, human eosinophil cationic protein (ECP) kit was performed to assay human ECP level in the bone marrow for the 16 ITP patients and 10 controls. As shown in Table 3 , ITP patients had higher levels of ECP expression compared with healthy controls (6985.66 ± 2332.25 vs 1068.36 ± 356.55, P \ 0.05).
4. The percentage of eosinophils in the bone marrow As shown in Table 4 the percentage of eosinophils of ITP patients in the bone marrow was higher, compared with control group (3.50 ± 0.50 vs 0.50 ± 0.30).
Discussion
Historically ITP-associated thrombocytopenia was attributed solely to sequestration of autoantibody-sensitized platelet in the reticuloendothelial system. Recently, Olsson et al. [2] reported several cytotoxic genes, such as Apo-I/ Fas, granzyme B and perforin, together with genes involve in the Th1 cell response, such as interferon-c and interleukin-2 receptor-R, showing increased expression in the ITP patients. With a modified 3 In release assay, Heyns Adu et al. [3] noted the destruction of autologous platelet by CD14
-and CD19 -mononuclear cells. The results provided the first evidence that the cell-mediated toxicity might mediate or participate in the pathogenesis of ITP.
Moreover, many authors have reported associations between the increased numbers of eosinophils with platelet dysfunctions, such as increased bleeding time, reduction in platelet aggregation induced by various agonists, among others disorders [4] [5] [6] . Recently, Maziero et al. [7] found that the eosinophil cationic protein (ECP) inhibited the platelet aggregation on platelet rich plasma and washed platelets.
These findings indicate that NK cells and eosinophil granulocytes may contribute to platelet destruction. To test this hypothesis we isolated the NK cells and eosinophil granulocytes from ITP patients and co-cultured them with autologous platelets to investigate whether the NK cells or eosinophil granulocytes contribute to cell-mediated lysis of autologous platelets in vivo. We found that the Annexin V positive platelets were highly increased in ITP patients when NK cells or eosinophil granulocytes were used as effector cells, suggesting that eosinophil granulocytes and NK cell-mediated cytotoxicity contribute to the destruction of platelets in ITP. FasL and TNF-a belong to TNF superfamily and may induce apoptosis after binding with their respective receptors, leading to immune attack in many autoimmune diseases [8] . In our study, FasL showed increased expression on the surface of NK cells in ITP Patients. We thought that interaction of upregulated FasL with their respective receptors on the surface of target cells may result in apoptosis of autologous platelets.
Furthermore, it is well known that granzyme and perforin are important functional proteins in cell-mediated toxicity [9, 10] . To test the specific mechanism of platelets destructions in ITP, we examined the granzyme B and perforin protein expressed in NK cells and found that granzyme B and perforin expression rate were high, demonstrating that the NK cells were abnormally activated in ITP patients which in turn directly destroyed the platelets by cytotoxicity, leading to thrombocytopenia. Apoptosis and perforin/granzyme-mediated cytotoxicity are two important pathways through which NK cells destruct autoplatelets.
Zhang et al. [1] found that platelets from patients with active ITP displayed in vitro lysis when incubated with CD3
? CD8 ? T effector cells but not with CD3 -CD16
?-
CD56
? natural killer (NK) cells. But our study indicated NK cells were abnormally activated, possibly due to the patient's plasma that we have added to the trial. The plasma contains antibodies directed against platelets, so NK cells can act on PLT by antibody-dependent cell-mediated cytotoxicity (ADCC).
Based on our observation, the percentage of eosinophils of ITP patients in the bone marrow was higher than that of the control group. Besides, our study found ITP patients had higher levels of ECP expression in the bone marrow than the healthy controls. ECP is a toxic protein released by activated eosinophils and it is also a specific marker of eosinophil activation. The ECP concentration is related to the number of activated eosinophils, which can directly reflect the number of eosinophils activation [11] . Because eosinophil surface has Fc receptor, we believe that eosinophil can also destroy platelets through ADCC.
Our study only examined the molecular expression related to cytotoxicity. Further studies are needed to identify the expression of their respective receptors so as to confirm and improve our hypothesis. In conclusion, eosinophil and NK-mediated cytotoxicity is an alternative mechanism for platelet destruction in ITP. This finding further enriched the theoretical content of pathogenesis of ITP, and provided a new way for targeted therapy of ITP. Blocking the activation of eosinophil and NK and their cytotoxicity might reduce platelet destruction and thereby have therapeutic effects. Besides, ECP assay is simple and might be used to monitor the development of ITP and judge prognosis.
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